GERA: A Collaboration of Genetics, the Environment and Cancer

The Genetic Epidemiology and Risk Assessment (GERA) Program uses observational studies with large numbers of patients and the community at large to study cancer patterns, risk factors and genes that predispose people to develop cancer. GERA investigators are examining molecular and other biomarkers and lifestyle reports to discern patients' habits and exposures to various elements and their relation to the onset of cancer. The resulting data is used to understand the causes of cancer and to look for ways to detect cancer earlier, enhance treatment, and to prevent cancer altogether.

Read More